Gingival overgrowth in renal transplant subjects medicated with tacrolimus in the absence of calcium channel blockers

Transplantation

Volumn 85, Issue 2, 2008, Pages 232-236

  Cezário, Erika S ^a   Cota, Luís O M ^b   Ferreira, Sérgio D ^b   Siqueira, Fernanda M ^b   Soares, Rodrigo V ^a   Zenóbio, Elton G ^a   Costa, Fernando O ^b  

^a PONTIFICAL CATHOLIC UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Calcium channel blockers; Gingival overgrowth; Kidney transplant; Risk variables; Tacrolimus

Indexed keywords

AZATHIOPRINE; CALCIUM CHANNEL BLOCKING AGENT; PREDNISOLONE; TACROLIMUS;

ADULT; ARTICLE; CHI SQUARE TEST; CONTROLLED STUDY; FEMALE; GINGIVA BLEEDING; GINGIVA OVERGROWTH; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RANK SUM TEST; STUDENT T TEST;

ADULT; AGED; AZATHIOPRINE; CALCIUM CHANNEL BLOCKERS; CHI-SQUARE DISTRIBUTION; DENTAL PLAQUE; FEMALE; GINGIVA; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PREDNISOLONE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TACROLIMUS; TIME FACTORS;

EID: 38549120655     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181604fad     Document Type: Article

References (32)

1. Costa FO, Ferreira SD, Cota LOM, Costa JE, Aguiar MA. Prevalence, severity, and risk variables associated with gingival overgrowth in renal transplant subjects treated under tacrolimus or cyclosporin regimens. J Periodontol 2006; 7: 969.
2. Halloran PF. Sirolimus and cyclosporine for renal transplantation. Lancet 2000; 356: 179.
3. Artz MA, Boots JMM, Ligtenberg G, et al. Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile. Am J Transplant 2004; 4: 937.
4. Cabezón S, Lage E, Hinojosa R, Ordonez A, Campos A. Sirolimus improves renal function in cardiac transplantation. Transplant Proc 2005; 37: 1546.
5. Morales JM, Andrés A, Dominguez-Gil B, et al. Ten years of treatment is related to an excellent renal function, allowing monotherapy in a large proportion of cases: Unicentric results of the tacrolimus versus cyclosporine A European multicentric study in kidney transplant patients. Transplant Proc 2005; 37: 3738.
6. Thomason JM, Seymour RA, Ellis JS. Risk factors for gingival overgrowth in patients medicated with cyclosporin in the absence of calcium channel blockers. J Clin Periodontol 2005; 32: 273.
7. Ellis JS, Seymour A, Taylor JJ, Thomason JM. Prevalence of gingival overgrowth in transplant patients immunossupressed with tacrolimus. J Clin Periodontol 2004; 31: 126.
8. Sekiguchi RT, Paixão CG, Saraiva L, Romito GA, Pannuti CM, Lotufo RF. Incidence of tacrolimus-induced gingival overgrowth in the absence of calcium channel blockers: A short-term study. J Clin Periodontol 2007; 34: 545.
9. James JA, Boomer S, Maxwell AP, et al. Reduction in gingival overgrowth associated with conversion from cyclosporin A to tacrolimus. J Clin Periodontol 2000; 27: 144.
10. James JA, Jamal S, Hull PS, et al. Tacrolimus is not associated with gingival overgrowth in renal transplant patients. J Clin Periodontol 2001; 28: 848.
11. McKaig SJ, Kelly D, Shaw L. Investigation of the effect of FK-506 (tacrolimus) and cyclosporin on gingival overgrowth following paediatric liver transplantation. Int J Paediatr Dent 2002; 12: 398.
12. Spolidorio LC, Spolidorio DMP, Massucato EMS, Nepplenbroek KH, Campanha NH, Sanches MH. Oral health in renal transplant recipients administered cyclosporin A or tacrolimus. Oral Dis 2006; 12: 309.
13. Kothari J, Nash M, Zaltzman J, Prasad GVR. Diltiazem use in tacrolimus-treated renal transplant recipients. J Clin Pharm Ther 2004; 29: 425.
14. Chen YH, Zheng KL, Chen LZ, et al. Clinical pharmacokinetics of tacrolimus after the first oral administration in combination with mycophenolate mofetil and prednisolone in Chinese renal transplant recipients. Transplant Proc 2005; 37: 4246.
15. Brown RS, Sein P, Corio R, Bottomley WK. Nitrendipine-induced gingival hyperplasia. First case report. Oral Surg Oral Med Oral Pathol 1990; 70: 593.
16. Lombardi T, Fiore-Donno G, Belser U, Di Felice R. Felodipine-induced gingival hyperplasia: A clinical and histologic study. J Oral Pathol Med 1991; 20: 89.
17. Seymour RA, Smith DG. The effect of a plaque control program on the incidence and severity of cyclosporin-induced gingival changes. J Clin Periodontol 1991; 18: 107.
18. Karpinia KA, Matt M, Fennell RS 3rd, Hefti AF. Factors affecting cyclosporin-induced gingival overgrowth in pediatric renal transplant recipients. Pediatr Dent 1996; 18: 450.
19. Jorgensen MG. Prevalence of amlodipine-related gingival hyperplasia. J Periodontol 1997; 68: 676.
20. van der Schaaf MR, Hene RJ, Floor M, Blankestijn PJ, Koomans HA. Hypertension after renal transplantation. Calcium channel blockers or converting enzyme blockade? Hypertension 1995; 25: 77.
21. Bokenkamp A, Bohnhorst B, Beier C, Albers N, Offner G, Brodehl J. Nifedipine aggravates ciclosporine A-induced gingival hyperplasia. Pediatr Nephrol 1994; 8: 181.
22. Margiotta V, Pizzo I, Pizzo G, Barbaro A. Cyclosporin and nifedipine-induced gingival overgrowth in renal transplant patients: Correlations with periodontal and pharmacological parameters and HLA-antigens. J Oral Pathol Med 1996; 25: 128.
23. Seymour RA. Effects of medications on the periodontal tissues in health and disease. Periodontol 2000 2006; 40: 120.
24. American Academy of Periodontology. Research, Science and Therapy Committee. Drug-associated gingival enlargement. J Periodontol 2004; 75:1424.
25. Silness J, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964; 22: 121.
26. Saxer UP, Mühlemann HR. Motivation and education. SSO Schweiz Monatsschr Zahnheilkd 1975; 85: 905.
27. Costa FO, Ferreira SD, Lages EJP, Costa JE, Oliveira AMSD, Cota LOM. Demographic, pharmacologic, and periodontal variables for gingival overgrowth in subjects medicated with cyclosporin in the absence of calcium channel blockers. J Periodontol 2007; 78: 254.
28. Thomason JM, Seymour RA, Rice N. The prevalence and severity of cyclosporin and nifedipine-induced gingival overgrowth. J Clin Periodontol 1993; 20: 37.
29. Seymour RA, Ellis JS, Thomason JM. 2000 Risk factors for drug-induced gingival overgrowth. J Clin Periodontol 2000; 27: 217.
30. Thomason, J., Kelly, P. & Seymour, R. The distribution of gingival overgrowth in organ transplant patients. J Clin Periodontol 1996; 23: 367.
31. Ellis JS, Morgan CL, Kirby JA, Taylor JJ, Thomason JM. Plasma TGF-β1 as a risk factor for gingival overgrowth. J Clin Periodontol 2004; 31: 863.
32. Seymour RA, Thomason JM, Ellis JS. The pathogenesis of drug-induced gingival overgrowth. J Clin Periodontol 1996; 23: 165.